Monica M. Bertagnolli, MD, FASCO

Dr. Monica Bertagnolli is the Richard E. Wilson Professor of Surgery in the Field of Surgical Oncology at Harvard Medical School and a member of the Gastrointestinal Cancer and Sarcoma Disease Centers at Dana-Farber/Brigham & Women’s Cancer Center, where she collaborates with colleagues in medical oncology, radiation oncology, and pathology to treat cancer patients in a tertiary care setting. Dr. Bertagnolli is also the Group Chair of the Alliance for Clinical Trials in Oncology, a nation-wide NCI-funded clinical trials group, and the Chief Executive Officer of Alliance Foundation Trials, LLC, a not-for-profit corporation that conducts international cancer clinical trials. Dr. Bertagnolli graduated from Princeton University and attended medical school at the University of Utah. Dr. Bertagnolli trained in surgery at Brigham & Women’s Hospital and was a research fellow in tumor immunology at the Dana Farber Cancer Institute (DF/BWCC). Dr. Bertagnolli currently serves on the Board of Directors of the Prevent Cancer Foundation and has served on the American Cancer Society Board of Directors since 2021.